Assignee
AMORSA THERAPEUTICS INC
US·7 granted patents·38 citations·filing 2014–2022
Top patents by PatentIndex Score
7 records- 0194US10653629B2Single layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2018·Granted May 19, 2020·6 cites·26 claims
- 0294US10252982B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2015·Granted Apr 9, 2019·14 cites·48 claims
- 0393US11613515B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2022·Granted Mar 28, 2023·2 cites·16 claims
- 0491US11554100B2Single-layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2020·Granted Jan 17, 2023·2 cites·17 claims
- 0590US11603348B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2021·Granted Mar 14, 2023·1 cites·16 claims
- 0690US9913803B2Single-layer oral dose of neuro-attenuating ketamineAMORSA THERAPEUTICS INC·Filed 2014·Granted Mar 13, 2018·12 cites·17 claims
- 0785US10981859B2Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methodsAMORSA THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·1 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when AMORSA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →